Andrei Pop
Latest contributions
Featured research: clinical outcomes and real-world evidence in modern TAVI practice
16 Nov 2025 – From PCR London Valves 2025
This session presents featured research on Transcatheter Aortic Valve Implantation (TAVI), analyzing clinical impacts of prosthesis oversizing, same-day discharge experiences, and comparative outcomes of intra-annular versus supra-annular self-expanding valves. It also reviews nationwide TAVR data from Germany and meta-analyses assessing TAVI performance in centers without on-site...
Expanding indications for TAVI - moderate aortic stenosis and heart failure
09 Feb 2025 – From PCR Tokyo Valves 2025
Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.
You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...
TAVI in challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the challenges of TAVI in complex anatomies, including cases of extremely horizontal aorta, extra-large aortic annulus with calcified amorphous tumour-like mass, severe atherosclerotic aorta complicated by severe aortic stenosis, transfemoral TAVI for severe aortic regurgitation with Stanford type B aortic dissection, and optimal TAVI...
TAVI challenging cases
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this session showcasing challenging TAVI cases and innovative solutions. Witness a successful TAVI case with immediate valve implantation following BAV in a severely calcified aortic valve. Explore a case where VR simulation helped enable easier coronary access during PCI after TAVI. Discover the management...
Lifetime management - First valve choice matters
08 Feb 2025 – From PCR Tokyo Valves 2025
In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.
